Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$25.91 +3.3%	$22.32	$19.10 ▼ $29.55	$1.20B	1.76	557,506 shs	652,188 shs
ESTA Establishment Labs	$43.63 +9.1%	$40.95	$26.56 ▼ $50.85	$1.16B	0.83	490,249 shs	389,764 shs
MDXG MiMedx Group	$7.31 +4.0%	$6.65	$5.47 ▼ $10.14	$1.04B	1.79	802,109 shs	1.08 million shs
STIM Neuronetics	$3.40 +0.6%	$3.78	$0.52 ▼ $5.92	$223.50M	1.78	1.32 million shs	1.90 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	+3.31%	+6.45%	+15.41%	+18.96%	+0.74%
ESTA Establishment Labs	+9.08%	+13.86%	+1.04%	+19.14%	-0.95%
MDXG MiMedx Group	+3.98%	+2.81%	+5.48%	+10.26%	+11.26%
STIM Neuronetics	+0.59%	+1.80%	-23.42%	-14.79%	+242.53%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLFS BioLife Solutions	2.5497 of 5 stars	2.6	3.0	3.5	2.5	0.6
ESTA Establishment Labs	1.9306 of 5 stars	3.4	0.0	2.0	2.5	0.6
MDXG MiMedx Group	3.2618 of 5 stars	3.5	4.0	3.2	1.7	0.6
STIM Neuronetics	2.3569 of 5 stars	3.5	1.0	3.8	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	3.13	Buy	$31.29	20.75% Upside
ESTA Establishment Labs	2.83	Moderate Buy	$56.50	29.50% Upside
MDXG MiMedx Group	3.00	Buy	$12.00	64.16% Upside
STIM Neuronetics	3.00	Buy	$7.00	105.88% Upside

Current Analyst Ratings Breakdown

Latest STIM, BLFS, MDXG, and ESTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2025	ESTA Establishment Labs	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$60.00
8/11/2025	BLFS BioLife Solutions	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/8/2025	BLFS BioLife Solutions	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $32.00
8/6/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $7.00
7/31/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$11.00 ➝ $12.00
7/22/2025	BLFS BioLife Solutions	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$30.00
7/16/2025	ESTA Establishment Labs	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$58.00 ➝ $70.00
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/9/2025	ESTA Establishment Labs	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$38.00 ➝ $47.00
6/13/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$82.25M	15.09	$0.13 per share	204.71	$7.25 per share	3.57
ESTA Establishment Labs	$177.42M	7.12	N/A	N/A	$0.79 per share	55.23
MDXG MiMedx Group	$348.88M	3.10	$0.34 per share	21.22	$1.46 per share	5.01
STIM Neuronetics	$74.89M	3.00	N/A	N/A	$0.48 per share	7.08

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$20.18M	-$0.12	N/A	N/A	N/A	-5.39%	0.16%	0.14%	11/11/2025 (Estimated)
ESTA Establishment Labs	-$84.60M	-$3.05	N/A	N/A	N/A	-49.89%	-224.34%	-25.53%	11/6/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.21	34.81	22.84	N/A	8.84%	23.03%	17.09%	10/29/2025 (Estimated)
STIM Neuronetics	-$43.71M	-$1.13	N/A	N/A	N/A	-43.47%	-156.36%	-35.69%	11/11/2025 (Estimated)

Latest STIM, BLFS, MDXG, and ESTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	BLFS BioLife Solutions	-$0.02	-$0.33	-$0.31	-$0.33	$23.71 million	$25.42 million
8/7/2025	Q2 2025	ESTA Establishment Labs	-$0.54	-$0.57	-$0.03	-$0.57	$50.80 million	$51.30 million
8/5/2025	Q2 2025	STIM Neuronetics	-$0.08	-$0.15	-$0.07	-$0.15	$36.80 million	$38.11 million
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	$0.10	+$0.04	$0.06	$90.79 million	$98.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	N/A	4.43	3.45
ESTA Establishment Labs	9.71	2.84	1.67
MDXG MiMedx Group	0.08	4.39	3.90
STIM Neuronetics	1.76	2.02	1.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
ESTA Establishment Labs	72.91%
MDXG MiMedx Group	79.15%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
ESTA Establishment Labs	11.09%
MDXG MiMedx Group	1.70%
STIM Neuronetics	8.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	440	47.90 million	46.85 million	Optionable
ESTA Establishment Labs	1,018	28.97 million	25.76 million	Optionable
MDXG MiMedx Group	870	147.96 million	145.44 million	Optionable
STIM Neuronetics	180	66.12 million	60.37 million	Optionable

STIM, BLFS, MDXG, and ESTA Headlines

Recent News About These Companies

104,597 Shares in Neuronetics, Inc. (NASDAQ:STIM) Purchased by Informed Momentum Co LLC

August 15, 2025 | marketbeat.com

Citizens Financial Group Inc. RI Invests $305,000 in Neuronetics, Inc. (NASDAQ:STIM)

August 10, 2025 | marketbeat.com

Canaccord Genuity Group Has Lowered Expectations for Neuronetics (NASDAQ:STIM) Stock Price

August 7, 2025 | marketbeat.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 6, 2025 | globenewswire.com

Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript

August 6, 2025 | msn.com

Neuronetics (NASDAQ:STIM) Announces Quarterly Earnings Results, Misses Expectations By $0.07 EPS

August 6, 2025 | marketbeat.com

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

August 5, 2025 | seekingalpha.com

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

August 5, 2025 | manilatimes.netM

What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings

August 5, 2025 | finance.yahoo.com

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

August 5, 2025 | zacks.com

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

August 4, 2025 | globenewswire.com

Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS

August 2, 2025 | msn.com

Neuronetics (STIM) Projected to Post Earnings on Tuesday

July 30, 2025 | marketbeat.com

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025 | globenewswire.com

Kestra Private Wealth Services LLC Purchases Shares of 68,977 Neuronetics, Inc. (NASDAQ:STIM)

July 29, 2025 | marketbeat.com

Nkcfo LLC Takes Position in Neuronetics, Inc. (NASDAQ:STIM)

July 28, 2025 | marketbeat.com

Neuronetics taps local industry veteran as new CFO

July 15, 2025 | bizjournals.com

Neuronetics Names Pfanstiel as CFO to Succeed Furlong

July 15, 2025 | marketwatch.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | finance.yahoo.com

Neuronetics names Steven Pfanstiel chief financial officer

July 15, 2025 | massdevice.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

STIM, BLFS, MDXG, and ESTA Company Descriptions

BioLife Solutions NASDAQ:BLFS

$25.91 +0.83 (+3.31%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$25.91 +0.00 (+0.00%)

As of 08/22/2025 05:09 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Establishment Labs NASDAQ:ESTA

$43.63 +3.63 (+9.08%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$43.64 +0.01 (+0.02%)

As of 08/22/2025 07:39 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

MiMedx Group NASDAQ:MDXG

$7.31 +0.28 (+3.98%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$7.30 0.00 (-0.07%)

As of 08/22/2025 04:10 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Neuronetics NASDAQ:STIM

$3.40 +0.02 (+0.59%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.42 +0.02 (+0.59%)

As of 08/22/2025 07:43 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time